semaglutide intestinal paralysis class action in west virginia Wegovy Stomach Lawsuit semaglutide intestinal paralysis class action

The medullary thyroid carcinoma warning All GLP-1 receptor agonists carry a black-box warning, the most serious warning the FDA issues, regarding thyroid C-cell tumors

The connection between mental health and weight is real, and so is the connection between hormones and metabolism

Any use of GLP-1 receptor agonists for PCOS should involve shared decision-making between patient and clinician, with clear discussion of the off-label nature of treatment and monitoring requirements

Why Weight Loss May Plateau on GLP-1 Treatment Patients frequently experience substantial weight loss during the initial months of GLP-1 therapy, but many notice a plateau effect where weight reduction slows or stabilises after 612 months of treatment

It just feels like the celebrity experience that we hear about, where it's like, oh, wow, in one year, this person went from like 300 pounds to like 100 pounds, I think that's what people expect, she says

Gradual dose titration and adequate hydration minimize age-related tolerability issues